Topical prostaglandin F(2α) treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway

Archives of Ophthalmology

Volumn 117, Issue 6, 1999, Pages 794-801

  Sagara, Takeshi ^a   Gaton, Dan D ^a   Lindsey, James D ^a   Gabelt, B'Ann True ^b   Kaufman, Paul L ^b   Weinreb, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; DRUG VEHICLE; EYE DROPS; PARAFFIN; PROSTAGLANDIN F2 ALPHA ISOPROPYL ESTER; COLLAGEN; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ISOPROPYL ESTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR OUTFLOW; ARTICLE; CILIARY MUSCLE; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MONKEY; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; SCLERA; TOPICAL DRUG ADMINISTRATION; UVEA; ANIMAL; AQUEOUS HUMOR; CILIARY BODY; ENZYME IMMUNOASSAY; MACACA; METABOLISM; PATHOLOGY; SECRETION; SMOOTH MUSCLE;

ADMINISTRATION, TOPICAL; ANIMALS; AQUEOUS HUMOR; CILIARY BODY; COLLAGEN; DINOPROST; IMMUNOENZYME TECHNIQUES; INTRAOCULAR PRESSURE; MACACA FASCICULARIS; MUSCLE, SMOOTH; OPHTHALMIC SOLUTIONS; SCLERA;

EID: 0032588080     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.6.794     Document Type: Article

References (40)

1. 2α-1-isopropylester in the cynomolgus monkey. Exp Eye Res. 1989;48:707-716.
2. 2α increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 1989;49:389-402.
3. 2α on aqueous humor dynamics in cynomolgus monkeys. Curr Eye Res. 1987;6:1035-1044.
4. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology. 1993;100: 1297-1304.
5. 2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol. 1993;111:1351-1358.
6. Mishima HK, Kiuchi Y, Takamatsu M, Racz P, Bito LZ. Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow. Surv Ophthalmol. 1997:41(suppl):S139-S144.
7. Wood RL, Koseki T, Kelly DE. Uveoscleral permeability to intracamerally infused ferritin in eyes of rabbits and monkeys. Cell Tissue Res. 1992;270:559-567.
8. Inomata H, Bill A, Smelser GK. Unconventional routes of aqueous humor outflow in cynomolgus monkey (Macaca irus). Am J Ophthalmol. 1972;73:893-907.
9. 2α-isopropylester on anterior segment morphology. Prog Clin Biol Res. 1989;312:437-446.
10. 2α: an ultrastructural study in rhesus and cynomolgus monkeys. Mech Ageing Dev. 1990; 51:101-110.
11. Lindsey J, Kashiwagi K, Kashiwagi F, Weinreb R. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci. 1997;38:2214-2223.
12. Tamm E, Baur A, Lutjen-Drecoll E. Synthesis of extracellular matrix components by human ciliary muscle cells in culture. Curr Eye Res. 1992;11:333-341.
13. Weinreb RN, Lindsey J, Luo XX, Wang T-H. Extracellular matrix of the human ciliary muscle. J Glaucoma. 1994;3:70-78.
14. Marshall GE, Konstas AG, Abraham S, Lee WR. Extracellular matrix in aged human ciliary body: an immunoelectron microscope study. Invest Ophthalmol Vis Sci. 1992;33:2546-2560.
15. Lindsey JD, Kashiwagi K, Boyle D, et al. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res. 1996; 15:869-875.
16. Weinreb RN, Kashiwagi K, Kashiwagi F, Lindsey JD. Prostaglandins increase metalloproteinase activity in medium of human ciliary smooth muscle cells in vitro. Invest Ophthalmol Vis Sci. 1997;38:2772-2780.
17. Lindsey J, Kashiwagi K, Kashiwagi F, Weinreb R. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. Survey Ophthalmol. 1997;42(suppl):S53-S59.
18. 2α-1-isopropyl ester. Exp Eye Res. 1987;44:217-226.
19. Kaufman P, Davis G. "Minified" Goldmann applanating prism for tonometry in monkeys and humans. Arch Ophthalmol. 1980;98:542-546.
20. 2α effects on isolated rhesus monkey ciliary muscle. Invest Ophthalmol Vis Sci. 1995;36:2461-2465.
21. Lalani EN, Golding M, Hudson M, et al. Protein extraction and Western blotting from methacarn-fixed tissue. J Pathol. 1995;177:323-328.
22. Shetye JD, Scheynius A, Mellstedt HT, Biberfeld P. Retrieval of leukocyte antigens in paraffin-embedded rat tissues. J Histochem Cytochem. 1996;44:767-776.
23. Gaton D, Sagara T, Lindsey J, Weinreb R. Matrix metalloproteinase-1 localization in the normal human uveoscleral outflow pathway. Invest Ophthalmol Vis Sci. 1998;40:363-369.
24. Raviola G, Freddo TF. A simple staining method for blood vessels in flat preparations of ocular tissues. Invest Ophthalmol Vis Sci. 1980;19:1518-1521.
25. Alexander RA, Hiscott PS, Hart RL, Grierson I. Effect of melanin bleaching on immunoperoxidase, with reference to ocular tissues and lesions. Med Lab Sci. 1986;43:121-127.
26. Foss AJ, Alexander RA, Jefferies LW, Lightman S. Immunohistochemical techniques: the effect of melanin bleaching. Br J Biomed Sci. 1995;52:22-25.
27. Amenta PS, Gay S, Vaheri A, Martinez-Hernandez A. The extracellular matrix is an integrated unit: ultrastructural localization of collagen types I, III, IV, V, VI, fibronectin, and laminin in human term placenta. Coll Relat Res. 1986;6:125-152.
28. Shekhonin BV, Domogatsky SP, Muzykantov VR, Idelson GL, Rukosuev VS. Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: immunomorphological characteristics. Coll Relat Res. 1985;5:355-368.
29. Rukosuev VS, Nanaev AK, Milovanov AP. Participation of collagen types I, III, IV, V, and fibronectin in the formation of villi fibrosis in human term placenta. Acta Histochem. 1990;89:11-16.
30. Gross DS, Rothfeld JM. Quantitative immunocytochemistry of hypothalamic and pituitary hormones: validation of an automated, computerized image analysis system. J Histochem Cytochem. 1985;33:11-20.
31. van der Loos CM, Marijianowski MM, Becker AE. Quantification in immunohistochemistry: the measurement of the ratios of collagen types I and II. Histochem J. 1994;26:347-354.
32. Yurchenco PD, Furthmayr H. Self-assembly of basement membrane collagen. Biochemistry. 1984;23:1839-1850.
33. Nagase H. Matrix metalloproteinases: a mini-review. Contrib Nephrol. 1994;107: 85-93.
34. Nagase H, Fields GB. Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. Biopolymers. 1996;40: 399-416.
35. Gaton DD, Sagara T, Lindsey JD, Weinreb RN. Matrix metalloproteinase-1 localization in the normal human uveoscleral outflow pathway. Invest Ophthalmol Vis Sci. 1999;40:363-369.
36. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle: a study on cultured cells and tissue sections. Exp Eye Res. 1998;67:179-191.
37. 2α analogue. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:513-518.
38. Inomata H, Bill A. Exit sites of uveoscleral flow of aqueous humor in cynomolgus monkey eyes. Exp Eye Res. 1977;25:113-118.
39. Barsotti M, Bartels S, Freddo T, Kamm R. The source of protein in the aqueous humor of the normal monkey eye. Invest Ophthalmol Vis Sci. 1992;33:581-595.
40. Freddo T. The Glenn A. aqueous humor proteins: a key for unlocking glaucoma? Optom Vis Sci. 1993;70:263-270.